Encompass Health Co. (NYSE:EHC) Position Raised by Raymond James & Associates

Raymond James & Associates increased its position in shares of Encompass Health Co. (NYSE:EHCGet Rating) by 7.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 144,570 shares of the company’s stock after purchasing an additional 9,429 shares during the period. Raymond James & Associates’ holdings in Encompass Health were worth $6,539,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Worth Asset Management LLC bought a new stake in Encompass Health during the first quarter worth approximately $35,000. Eagle Bay Advisors LLC raised its holdings in Encompass Health by 137.5% during the second quarter. Eagle Bay Advisors LLC now owns 1,019 shares of the company’s stock worth $57,000 after purchasing an additional 590 shares in the last quarter. SeaCrest Wealth Management LLC bought a new stake in Encompass Health during the second quarter worth approximately $85,000. Covestor Ltd raised its holdings in Encompass Health by 157.1% during the first quarter. Covestor Ltd now owns 1,481 shares of the company’s stock worth $105,000 after purchasing an additional 905 shares in the last quarter. Finally, First Horizon Advisors Inc. grew its position in Encompass Health by 1,524.6% in the second quarter. First Horizon Advisors Inc. now owns 2,112 shares of the company’s stock worth $117,000 after buying an additional 1,982 shares during the last quarter. Institutional investors own 96.14% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on EHC shares. Credit Suisse Group decreased their price target on shares of Encompass Health from $63.00 to $62.00 and set an “outperform” rating on the stock in a research report on Wednesday, September 21st. Stephens decreased their price target on shares of Encompass Health from $60.00 to $58.00 and set an “overweight” rating on the stock in a research report on Friday, October 28th. Raymond James raised their price objective on shares of Encompass Health from $65.00 to $72.00 and gave the stock a “strong-buy” rating in a research note on Friday, October 28th. StockNews.com assumed coverage on shares of Encompass Health in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. Finally, TheStreet raised shares of Encompass Health from a “c+” rating to a “b-” rating in a research note on Wednesday, December 21st. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $64.13.

Encompass Health Stock Up 0.9 %

EHC stock opened at $61.02 on Friday. Encompass Health Co. has a 12-month low of $44.33 and a 12-month high of $74.61. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 1.59. The company has a market cap of $6.09 billion, a price-to-earnings ratio of 22.43, a PEG ratio of 2.55 and a beta of 1.03. The company has a 50 day moving average of $57.82 and a two-hundred day moving average of $52.85.

Encompass Health (NYSE:EHCGet Rating) last released its earnings results on Wednesday, October 26th. The company reported $0.67 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.01). Encompass Health had a return on equity of 15.59% and a net margin of 5.39%. The company had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.06 billion. On average, equities analysts anticipate that Encompass Health Co. will post 2.79 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.98%. The ex-dividend date is Friday, December 30th. Encompass Health’s payout ratio is presently 22.06%.

Insider Transactions at Encompass Health

In related news, Director Greg D. Carmichael bought 1,830 shares of the business’s stock in a transaction that occurred on Monday, October 31st. The stock was acquired at an average price of $54.67 per share, for a total transaction of $100,046.10. Following the transaction, the director now directly owns 10,546 shares of the company’s stock, valued at $576,549.82. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.70% of the stock is owned by insiders.

Encompass Health Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Featured Articles

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCGet Rating).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.